PTK2 and neoplasm: Targeting focal adhesion kinase components, such as FAK and Src, can prevent the process of tumour matrix fibrosis by inhibiting mechanotransduction at focal adhesion and thus inhibiting, for example, the phenotypic transformation of myofibroblasts and fibroblast migration [413].